The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 08, 2022

Filed:

Jan. 13, 2017
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Varghese John, Los Angeles, CA (US);

Jesus Campagna, Playa Del Rey, CA (US);

Tina Bilousova, Santa Monica, CA (US);

Patricia R. Spilman, Mill Valley, CA (US);

Peter James Heinzelman, Los Angeles, CA (US);

Asa Hatami, Los Angeles, CA (US);

Mohammad Parvez Alam, Los Angeles, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/543 (2006.01); G01N 33/68 (2006.01); G01N 33/542 (2006.01); C07D 207/46 (2006.01); G01N 33/567 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6896 (2013.01); C07D 207/46 (2013.01); G01N 33/542 (2013.01); G01N 33/54313 (2013.01); G01N 33/54326 (2013.01); G01N 33/54353 (2013.01); G01N 33/567 (2013.01); G01N 33/57484 (2013.01); G01N 2570/00 (2013.01); G01N 2800/285 (2013.01); G01N 2800/2821 (2013.01); G01N 2800/2835 (2013.01); G01N 2800/52 (2013.01);
Abstract

In various embodiments methods are provided for identifying and/or quantifying one or more antigens of interest (biomarkers) on the surface of cell- or tissue-specific exosomes. In an illustrative embodiments the methods comprise: i) incubating a population of exosomes with one or more tissue-specific antibodies that bind an antigen specific to a tissue or cell type of interest that produces exosomes, where the tissue specific antibodies are attached to acceptor bead or magnetic beads so the antibodies bind exosomes displaying the antigen; ii) obtaining a purified population of exosomes bound by the tissue specific antibodies with and/or without photocleavable linker based technology; iii) incubating a test subset of the isolated tissue-specific exosomes with acceptor beads attached to test antibodies that bind an antigen of interest thereby binding exosomes that display the antigen of interest and a control subset with negative control acceptor beads; v) incubating the test subset of isolated exosomes and the control subset of exosomes with a donor-bearing antibody that binds an exosome specific antigen; and vi) detecting a signal produced upon illumination of the control subset and/or the test; and vii) detecting the antigen(s) of interest.


Find Patent Forward Citations

Loading…